Clinical trial
Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral…
NCT00226499 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00226499 |
|---|---|
| Title | Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox |
| Official title | Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Varicella, Chickenpox Vaccines |
| Intervention type | Biological |
| Interventions | Priorix-tetra™, Priorix™, Varilrix™ |
| Enrollment | 5,803 |
| Start date | Sep 1, 2005 |
| Primary completion | Oct 12, 2006 |
| Completion | Oct 12, 2006 |
| First posted | Sep 27, 2005 |
| Last update posted | Sep 23, 2019 |
| Countries | Czechia, Greece, Italy, Lithuania, Norway, Poland, Romania, Russia, Slovakia, Sweden |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: